Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jim Brown, President and CEO of DURECT Corporation, for a conversation on the importance of a pharmacoeconomic strategy, developing new treatments for alcohol associated hepatitis, and moving beyond what a single individual can do in clinical research. Tune in today!

Episode metadata supplied by the publisher feed · Published Jul 22, 2025

Embed this episode

Attribution link and audio player

Ready to play

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

0:00 44:53

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 44 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on July 22, 2025.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!